ADC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
[Advanced]

The most recent version of this article was published on 1 July 2008

Arch Dis Child. Published Online First: 1 April 2008. doi:10.1136/adc.2007.120493
Copyright © 2008 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health

This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
adc.2007.120493v1
93/7/620    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in ADC Online
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haworth, S. G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haworth, S. G

Review

The management of pulmonary hypertension in children

Sheila G Haworth 1*

1 Department of Paediatric Cardiology, United Kingdom

* To whom correspondence should be addressed. E-mail: s.haworth{at}ich.ucl.ac.uk.

Accepted 26 March 2008


*   Abstract

Pulmonary hypertension is relatively common in children and has many causes. The management of the condition has changed dramatically in the last five years with the introduction of new medicines.

Diagnosis, investigation and choice of therapy remain a challenge. In 2002 the United Kingdom Pulmonary Hypertension Service for Children was established and this has become the mainstay of management in this country. This Service, based at Great Ormond Street Hospital for Children, provides advice, expertise and infrastructure support for the most severely affected, particularly those with Idiopathic Pulmonary Arterial Hypertension for whom chronic intravenous prostacyclin remains the most effective medication.

New medicines are being developed which rather than focussing on dilating a diseased pulmonary vascular bed, aim to structurally remodel the pulmonary vasculature towards normal.








HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
ARCH DIS CHILD FETAL NEONATAL ED ED PRACTICE
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2008 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health